{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:10:33Z","timestamp":1791666633755,"version":"4.3.4"},"reference-count":21,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Center for Science in Poland","award":["2017\/25\/N\/NZ5\/02689"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02689"]}]},{"name":"Medical University of Bialystok","award":["2017\/25\/N\/NZ5\/02689"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02689"]}]},{"name":"leading national research center","award":["2017\/25\/N\/NZ5\/02689"],"award-info":[{"award-number":["2017\/25\/N\/NZ5\/02689"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: In pulmonary arterial hypertension (PAH), there is still a need for new prognostic markers to precisely identify patients before clinical deterioration. We investigated the right ventricle cardiac power index (RV CPI) as a tool to assess RV function. We also hypothesized that hemodynamic changes occurring in PAH assessed with the RV CPI are related with cardiac metabolism alterations in PET imaging, which affects prognosis. Methods: Twenty-eight stable PAH patients (51.4 \u00b1 15.9 years old) had PET\/CMR and heart catheterization performed at baseline and after 24 months. The PET-derived SUV RV\/LV ratio was used to estimate cardiac glucose uptake. Clinical endpoints (CEPs\u2014death or clinical deterioration) were assessed between visits. The RV CPI was defined as cardiac index \u00d7 mean pulmonary artery pressure \u00d7 2.22 \u00d7 10\u22123. Results: The baseline RV CPI was 0.28 \u00b1 0.09 W\/m2 and correlated significantly with the SUV RV\/LV ratio (r = 0.55, p = 0.002), confirming a relationship between RV hemodynamics and glucose metabolism. After 24 months of PAH-specific therapy, we observed significant improvement in the follow-up RV CPI\u20140.23 \u00b1 0.04 W\/m2 (p = 0.04). During 2-year observations, 16 patients (57%) experienced CEPs (including four deaths). Patients with CEPs had a higher baseline CPI than stable patients (0.32 \u00b1 0.09 vs. 0.21 \u00b1 0.05, p = 0.0006). The cut-off value of the RV CPI to predict worse prognosis was 0.24 W\/m2 (log-rank test, p = 0.003). Conclusions: To sum up, the indexed cardiac power output parameter may reflect RV efficiency and is related to its glucose metabolism alterations in PAH. Its low value may help to identify stable patients at higher risk of death or clinical deterioration in long-term prognosis.<\/jats:p>","DOI":"10.3390\/jcm14041062","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:02:42Z","timestamp":1738918962000},"page":"1062","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of the Right Ventricle Cardiac Power Index with Glucose Metabolism and Prognosis in Pulmonary Arterial Hypertension Patients\u2014PET\/MRI Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4517-1498","authenticated-orcid":false,"given":"Remigiusz","family":"Kazimierczyk","sequence":"first","affiliation":[{"name":"Department of Cardiology and Internal Diseases, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-6583","authenticated-orcid":false,"given":"Piotr","family":"Szumowski","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8817-1482","authenticated-orcid":false,"given":"Stephan G.","family":"Nekolla","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Technical University Munich, 81675 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-0163","authenticated-orcid":false,"given":"Lukasz A.","family":"Malek","sequence":"additional","affiliation":[{"name":"Faculty of Rehabilitation, University of Physical Education, 04-628 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Blaszczak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardinal Wyszynski Hospital, 20-718 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3297-3320","authenticated-orcid":false,"given":"Bozena","family":"Sobkowicz","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Internal Diseases, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4125-6585","authenticated-orcid":false,"given":"Janusz","family":"Mysliwiec","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-6236","authenticated-orcid":false,"given":"Raymond L.","family":"Benza","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mount Sinai Health System, New York, NY 10029, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-2581","authenticated-orcid":false,"given":"Karol A.","family":"Kaminski","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Internal Diseases, Medical University of Bialystok, 15-089 Bialystok, Poland"},{"name":"Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-089 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacc.2004.03.060","article-title":"Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry","volume":"44","author":"Fincke","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/euhj.2000.2547","article-title":"Peak exercise cardiac power output; a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure","volume":"22","author":"Williams","year":"2001","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ejhf.268","article-title":"Prognostic role of cardiac power index in ambulatory patients with advanced heart failure","volume":"17","author":"Grodin","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ehjci\/jead242","article-title":"Pathophysiologic and prognostic importance of cardiac power output reserve in heart failure with preserved ejection fraction","volume":"25","author":"Takizawa","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ejhf.310","article-title":"Resting cardiac power index and prediction of prognosis in heart failure","volume":"17","author":"Hothi","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCIMAGING.121.013495","article-title":"Cardiac Power Output Is Independently and Incrementally Associated With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction","volume":"15","author":"Harada","year":"2022","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1002\/ehf2.14949","article-title":"Cardiac power output ratio: Novel survival predictor after percutaneous ventricular assist device in cardiogenic shock","volume":"11","author":"Leung","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_8","first-page":"100","article-title":"Left and right ventricular power: Outputs are the strongest hemodynamic correlates to allow identification of acute responders to vasodilator treatment in idiopathic pulmonary arterial hypertension","volume":"81","author":"Sandoval","year":"2011","journal-title":"Arch. Cardiol. Mex."},{"key":"ref_9","first-page":"794","article-title":"Right Ventricular Cardiac Power Output as a Mortality Predictor in Patients with Pulmonary Arterial Hypertension","volume":"11","author":"Sert","year":"2021","journal-title":"Sak. Med. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"Humbert","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/ehjci\/jev136","article-title":"Shifts in myocardial fatty acid and glucose metabolism in pulmonary arterial hypertension: A potential mechanism for a maladaptive right ventricular response","volume":"17","author":"Ohira","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/heartjnl-2020-316741","article-title":"Prognostic role of PET\/MRI hybrid imaging in patients with pulmonary arterial hypertension","volume":"107","author":"Kazimierczyk","year":"2021","journal-title":"Heart"},{"key":"ref_14","first-page":"16806","article-title":"What is the meaning of late gadolinium enhancement at right ventricular insertion points in pulmonary arterial hypertension?","volume":"134","author":"Kazimierczyk","year":"2024","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13550-023-00971-w","article-title":"The impact of specific pulmonary arterial hypertension therapy on cardiac fluorodeoxyglucose distribution in PET\/MRI hybrid imaging\u2013follow-up study","volume":"13","author":"Kazimierczyk","year":"2023","journal-title":"EJNMMI Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amjcard.2017.06.028","article-title":"Evaluation of Resting Cardiac Power Output as a Prognostic Factor in Patients with Advanced Heart Failure","volume":"120","author":"Yildiz","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107432","DOI":"10.1016\/j.vph.2024.107432","article-title":"Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus","volume":"157","author":"Manzi","year":"2024","journal-title":"Vasc. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/RLU.0000000000000956","article-title":"The Prognostic Value of 18F-FDG Uptake Ratio Between the Right and Left Ventricles in Idiopathic Pulmonary Arterial Hypertension","volume":"40","author":"Li","year":"2015","journal-title":"Clin. Nucl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/RLU.0000000000000422","article-title":"The ratio of (18)F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function","volume":"39","author":"Yang","year":"2014","journal-title":"Clin. Nucl. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcmg.2018.12.032","article-title":"Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejim.2024.03.003","article-title":"Effect of sodium-glucose cotransporter-2 inhibitors on pulmonary arterial wedge pressure","volume":"124","author":"Karakasis","year":"2024","journal-title":"Eur. J. Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1062\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:49Z","timestamp":1760027329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14041062"],"URL":"https:\/\/doi.org\/10.3390\/jcm14041062","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}